Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 2, 2008, Pages 387-397

  Zuo, Jing ^a   Liu, Zhening ^a   Ouyang, Xuan ^a   Liu, Haihong ^a   Hao, Yihui ^a   Xu, Lin ^a,b   Lu, Xiao Hong ^a,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Body growth; Fetal exposure; Locomotion; Risperidone; Sulpiride; Water maze

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN 2 ANTAGONIST; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; BEHAVIOR CHANGE; BIRTH WEIGHT; BODY GROWTH; BODY WEIGHT; BRAIN DEVELOPMENT; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; EMOTION; FEMALE; FETUS GROWTH; LEARNING; LOCOMOTION; MALE; MAZE TEST; MEMORY CONSOLIDATION; MOTOR PERFORMANCE; NEWBORN; NONHUMAN; OPEN FIELD TEST; PERINATAL PERIOD; PRENATAL EXPOSURE; PROGENY; RAT; SPATIAL MEMORY; SPRAGUE DAWLEY RAT; TASK PERFORMANCE; VISION;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; EXPLORATORY BEHAVIOR; FEMALE; GROWTH; MALE; MATERNAL EXPOSURE; MAZE LEARNING; MEMORY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; RISPERIDONE; SULPIRIDE;

EID: 38849131435     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.09.005     Document Type: Article

References (71)

1. Ago Y., Nakamura S., Baba A., and Matsuda T. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex. Neuropsychopharmacology 30 (2005) 43-51
2. Aichhorn W., Weiss U., Marksteiner J., Kemmler G., Walch T., Zernig G., et al. Influence of age and gender on risperidone plasma concentrations. J Psychopharmacol 19 (2005) 395-401
3. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1989) 366-375
4. Altshuler L.L., Cohen L., Szuba M.P., Burt V.K., Gitlin M., and Mintz J. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 153 (1996) 592-606
5. Aravagiri M., and Marder S.R. Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats. Psychopharmacology (Berl) 159 (2002) 424-431
6. Baik J.H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377 (1995) 424-428
7. Balant-Gorgia A.E., Gex-Fabry M., Genet C., and Balant L.P. Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factors. Ther Drug Monit 21 (1999) 105-115
8. Baptista T., Parada M., and Hernandez L. Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved?. Pharmacol Biochem Behav 27 (1987) 399-405
9. Baptista T., Mata A., Teneud L., de Quijada M., Han H.W., and Hernandez L. Effects of long-term administration of clozapine on body weight and food intake in rats. Pharmacol Biochem Behav 45 (1993) 51-54
10. Baptista T., de Baptista E.A., Hernandez L., Altemus M., and Weiss S.R. Tamoxifen prevents sulpiride-induced weight gain in female rats. Pharmacol Biochem Behav 57 (1997) 215-222
11. Baptista T., Contreras Q., Teneud L., Albornoz M.A., Acosta A., Paez X., et al. Mechanism of the neuroleptic-induced obesity in female rats. Prog Neuropsychopharmacol Biol Psychiatry 22 (1998) 187-198
12. Baptista T., Lacruz A., Paez X., Hernandez L., and Beaulieu S. The antipsychotic drug sulpiride does not affect bodyweight in male rats. Is insulin resistance involved?. Eur J Pharmacol 447 (2002) 91-98
13. Baptista T., de Baptista E.A., Lalonde J., Plamondon J., Kin N.M., Beaulieu S., et al. Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 1305-1311
14. Bressolle F., Bres J., and Faure-Jeantis A. Absolute bioavailability, rate of absorption, and dose proportionality of sulpiride in humans. J Pharm Sci 81 (1992) 26-32
15. Bruinink A., Lichtensteiger W., and Schlumpf M. Pre- and postnatal ontogeny and characterization of dopaminergic D2, serotonergic S2, and spirodecanone binding sites in rat forebrain. J Neurochem 40 (1983) 1227-1236
16. Brunner D., Buhot M.C., Hen R., and Hofer M. Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice. Behav Neurosci 113 (1999) 587-601
17. Caley C.F., and Weber S.S. Sulpiride: an antipsychotic with selective dopaminergic antagonist properties. Ann Pharmacother 29 (1995) 152-160
18. Casiano M.E., and Hawkins D.R. Major mental illness and childbearing. A role for the consultation-liaison psychiatrist in obstetrics. Psychiatr Clin North Am 10 (1987) 35-51
19. Cohen L.S., and Rosenbaum J.F. Psychotropic drug use during pregnancy: weighing the risks. J Clin Psychiatry 59 Suppl 2 (1998) 18-28
20. Costa L.G., Steardo L., and Cuomo V. Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects. Pharmacol Rev 56 (2004) 103-147
21. D'Hooge R., and De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36 (2001) 60-90
22. DeLong M.R., and Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 64 (2007) 20-24
23. Devan B.D., and White N.M. Parallel information processing in the dorsal striatum: relation to hippocampal function. J Neurosci 19 (1999) 2789-2798
24. Devan B.D., McDonald R.J., and White N.M. Effects of medial and lateral caudate-putamen lesions on place- and cue-guided behaviors in the water maze: relation to thigmotaxis. Behav Brain Res 100 (1999) 5-14
25. Di Matteo V., Cacchio M., Di Giulio C., Di Giovanni G., and Esposito E. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo. Pharmacol Biochem Behav 71 (2002) 607-613
26. Fell M.J., Neill J.C., Rao C., and Marshall K.M. Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats. Psychopharmacology (Berl) 182 (2005) 499-507
27. Francia N., Cirulli F., Chiarotti F., Antonelli A., Aloe L., and Alleva E. Spatial memory deficits in middle-aged mice correlate with lower exploratory activity and a subordinate status: role of hippocampal neurotrophins. Eur J Neurosci 23 (2006) 711-728
28. Gengler S., Mallot H.A., and Holscher C. Inactivation of the rat dorsal striatum impairs performance in spatial tasks and alters hippocampal theta in the freely moving rat. Behav Brain Res 164 (2005) 73-82
29. Green M.F., Marder S.R., Glynn S.M., McGurk S.R., Wirshing W.C., Wirshing D.A., et al. The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone. Biol Psychiatry 51 (2002) 972-978
30. Holson R.R., Webb P.J., Grafton T.F., and Hansen D.K. Prenatal neuroleptic exposure and growth stunting in the rat: an in vivo and in vitro examination of sensitive periods and possible mechanisms. Teratology 50 (1994) 125-136
31. Horacek J., Bubenikova-Valesova V., Kopecek M., Palenicek T., Dockery C., Mohr P., et al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs 20 (2006) 389-409
32. Ichikawa J., Ishii H., Bonaccorso S., Fowler W.L., O'Laughlin I.A., and Meltzer H.Y. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76 (2001) 1521-1531
33. Kapur S., and Remington G. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med 52 (2001) 503-517
34. Karl T., Duffy L., O'Brien E., Matsumoto I., and Dedova I. Behavioural effects of chronic haloperidol and risperidone treatment in rats. Behav Brain Res 171 (2006) 286-294
35. Kelly M.A., Rubinstein M., Phillips T.J., Lessov C.N., Burkhart-Kasch S., Zhang G., et al. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 18 (1998) 3470-3479
36. Lin E.J., Lee N.J., Slack K., Karl T., Duffy L., O'Brien E., et al. Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats. Neuropharmacology 51 (2006) 1129-1136
37. Luparini M.R., Del Vecchio A., Barillari G., Magnani M., and Prosdocimi M. Cognitive impairment in old rats: a comparison of object displacement, object recognition and water maze. Aging (Milano) 12 (2000) 264-273
38. Marek G.J. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development. Int Rev Neurobiol 78 (2007) 165-192
39. McDonald R.J., and White N.M. Parallel information processing in the water maze: evidence for independent memory systems involving dorsal striatum and hippocampus. Behav Neural Biol 61 (1994) 260-270
40. Mehta M.A., Sahakian B.J., McKenna P.J., and Robbins T.W. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Psychopharmacology (Berl) 146 (1999) 162-174
41. Meller E., Bordi F., and Bohmaker K. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors. Life Sci 44 (1989) 1019-1026
42. Meltzer H.Y., and McGurk S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25 (1999) 233-255
43. Miller L.J. Sexuality, reproduction, and family planning in women with schizophrenia. Schizophr Bull 23 (1997) 623-635
44. Mizuno N., Morita E., Nishikata M., Shinkuma D., and Yamanaka Y. Gastrointestinal absorption of sulpiride in rat. Arch Int Pharmacodyn Ther 283 (1986) 30-38
45. Moody C.A., Robinson S.R., Spear L.P., and Smotherman W.P. Fetal behavior and the dopamine system: activity effects of D1 and D2 receptor manipulations. Pharmacol Biochem Behav 44 (1993) 843-850
46. Morris R.G., Garrud P., Rawlins J.N., and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297 (1982) 681-683
47. Obuchowicz E., and Turchan J. Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat. Eur Neuropsychopharmacol 9 (1999) 51-59
48. Ota M., Mori K., Nakashima A., Kaneko Y.S., Fujiwara K., Itoh M., et al. Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats. Clin Exp Pharmacol Physiol 29 (2002) 980-989
49. Packard M.G., and McGaugh J.L. Double dissociation of fornix and caudate nucleus lesions on acquisition of two water maze tasks: further evidence for multiple memory systems. Behav Neurosci 106 (1992) 439-446
50. Packard M.G., and Knowlton B.J. Learning and memory functions of the basal ganglia. Annu Rev Neurosci 25 (2002) 563-593
51. Parada M.A., Hernandez L., and Hoebel B.G. Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats. Pharmacol Biochem Behav 30 (1988) 917-923
52. Parada M.A., Hernandez L., Paez X., Baptista T., Puig de Parada M., and de Quijada M. Mechanism of the body weight increase induced by systemic sulpiride. Pharmacol Biochem Behav 33 (1989) 45-50
53. Patton S.W., Misri S., Corral M.R., Perry K.F., and Kuan A.J. Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk. Can J Psychiatry 47 (2002) 959-965
54. Redish A.D., and Touretzky D.S. The role of the hippocampus in solving the Morris water maze. Neural Comput 10 (1998) 73-111
55. Riedel M., Schwarz M.J., Strassnig M., Spellmann I., Muller-Arends A., Weber K., et al. Risperidone plasma levels, clinical response and side-effects. Eur Arch Psychiatry Clin Neurosci 255 (2005) 261-268
56. Rinaldi A., Mandillo S., Oliverio A., and Mele A. D1 and D2 receptor antagonist injections in the prefrontal cortex selectively impair spatial learning in mice. Neuropsychopharmacology 32 (2007) 309-319
57. Rosengarten H., and Quartermain D. Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats. Pharmacol Biochem Behav 72 (2002) 575-579
58. Rowe W.B., Spreekmeester E., Meaney M.J., Quirion R., and Rochford J. Reactivity to novelty in cognitively-impaired and cognitively-unimpaired aged rats and young rats. Neuroscience 83 (1998) 669-680
59. Segura J., Borja L., and Bakke O.M. Pharmacokinetics of sulpiride after oral and intravenous administration in the rat and the dog. Arch Int Pharmacodyn Ther 223 (1976) 88-95
60. Tang K., Low M.J., Grandy D.K., and Lovinger D.M. Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci U S A 98 (2001) 1255-1260
61. Terry Jr. A.V., Hill W.D., Parikh V., Waller J.L., Evans D.R., and Mahadik S.P. Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats. Neuropsychopharmacology 28 (2003) 300-309
62. Tokunaga H., Kudo K., Jitsufuchi N., Ohtsuka Y., and Imamura T. Sensitive determination of sulpiride in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 691 (1997) 203-207
63. Trixler M., Gati A., Fekete S., and Tenyi T. Use of antipsychotics in the management of schizophrenia during pregnancy. Drugs 65 (2005) 1193-1206
64. Watanabe K., Sawano T., Jinriki T., and Sato J. Studies on intestinal absorption of sulpiride (3): intestinal absorption of sulpiride in rats. Biol Pharm Bull 27 (2004) 77-81
65. Williams R., Ali S.F., Scalzo F.M., Soliman K., and Holson R.R. Prenatal haloperidol exposure: effects on brain weights and caudate neurotransmitter levels in rats. Brain Res Bull 29 (1992) 449-458
66. Willig F., Palacios A., Monmaur P., M'Harzi M., Laurent J., and Delacour J. Short-term memory, exploration and locomotor activity in aged rats. Neurobiol Aging 8 (1987) 393-402
67. Woodward N.D., Purdon S.E., Meltzer H.Y., and Zald D.H. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol 8 (2005) 457-472
68. Xu L., Anwyl R., and Rowan M.J. Behavioural stress facilitates the induction of long-term depression in the hippocampus. Nature 387 (1997) 497-500
69. Xu L., Anwyl R., and Rowan M.J. Spatial exploration induces a persistent reversal of long-term potentiation in rat hippocampus. Nature 394 (1998) 891-894
70. Yaeger D., Smith H.G., and Altshuler L.L. Atypical antipsychotics in the treatment of schizophrenia during pregnancy and the postpartum. Am J Psychiatry 163 (2006) 2064-2070
71. Zhang G., Terry Jr. A.V., and Bartlett M.G. Liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat plasma. Rapid Commun Mass Spectrom 21 (2007) 920-928